Use of Posaconazole in the Treatment of Infective Rhinocerebral Mucormycosis

Journal of Laryngology and Otology - United Kingdom
doi 10.1017/s0022215110000678
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cambridge University Press (CUP)

Related search

Rhinocerebral Mucormycosis —Case Report—

Neurologia Medico-Chirurgica
SurgeryNeurology
1993English

Long-Term Survival in Rhinocerebral Mucormycosis

Journal of Neurosurgery
SurgeryNeurology
1998English

Rhinocerebral Mucormycosis. Report of a Case and Review of Literature

Practica Otologica
Otorhinolaryngology
1976English

Rhinocerebral Mucormycosis in a Patient With Acute Promyelocytic Leukemia

Turkish Journal of Haematology
Hematology
2015English

A Case of Successfully Treated Rhinocerebral Mucormycosis: Dental Implications

International Journal of Dentistry
Dentistry
2010English

Pmu56 - Economic Evaluation of Posaconazole in Comparison With Liposomal Amphotericin B in the Treatment of Mucormycosis in Iran

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Looks Like Tuberculous Meningitis, but Not: A Case of Rhinocerebral Mucormycosis With Garcin Syndrome

Frontiers in Neurology
Neurology
2016English

Treatment by Posaconazole Tablets Did Not Reduced Variability of Posaconazole Trough Concentrations Compared to Posaconazole Suspension

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Rhinocerebral Mucormycosis Treated With 32 Gram Liposomal Amphotericin B and Incomplete Surgery: A Case Report

BMC Infectious Diseases
Infectious Diseases
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy